Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1987 Dec 1;248(2):449–454. doi: 10.1042/bj2480449

The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L.

R W Mason 1, S Gal 1, M M Gottesman 1
PMCID: PMC1148562  PMID: 3435459

Abstract

The major excreted protein (MEP) purified from Kirsten-virus-transformed 3T3 fibroblasts and mature human cathepsin L were compared in respect to a number of catalytic criteria and found to be similar. The Mr of MEP is 39,000, whereas that of mature human cathepsin L is 30,000. Sequence data suggested that MEP could be a pro-form of mouse cathepsin L. Both enzymes acted on the synthetic substrate benzyloxycarbonyl-Phe-Arg-7-(4-methyl)coumarylamide with similar catalytic constants and acted optimally at pH 5.5. Both were rapidly inactivated by the active-site-directed inhibitors benzyloxycarbonyl-Phe-Phe-diazomethane and L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-guanidin o)butane, and furthermore, 3H-labelled L-3-carboxy-trans-2,3-epoxypropionyl-leucylamido-(4-acetamid o)butane, which binds covalently to the heavy chain of mature cathepsin L, also bound to MEP. MEP autolyses rapidly at pH 3.0 to give lower-Mr (35,000 and 30,000) forms, but all forms react with the radiolabelled inhibitor. No autolysis occurred above pH 5.0. MEP hydrolysed azocasein at pH 5.0, demonstrating that it is capable of hydrolysing protein substrates without autolytic activation. Unlike mature forms of cathepsin L, MEP is stable, but not active, at neutral pH. The present work shows that cathepsin L can be secreted as a higher-Mr precursor that is stable in extracellular fluids but only active where local pH values fall below 6.0. These results suggest that the extra N-terminal peptide on MEP is not an activation peptide, but is a regulatory peptide affecting the pH-stability and activity of mouse cathepsin L.

Full text

PDF
449

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett A. J., Kembhavi A. A., Brown M. A., Kirschke H., Knight C. G., Tamai M., Hanada K. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982 Jan 1;201(1):189–198. doi: 10.1042/bj2010189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett A. J., Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 1981;80(Pt 100):535–561. doi: 10.1016/s0076-6879(81)80043-2. [DOI] [PubMed] [Google Scholar]
  3. Burnett D., Crocker J., Stockley R. A. Cathepsin B-like cysteine proteinase activity in sputum and immunohistologic identification of cathepsin B in alveolar macrophages. Am Rev Respir Dis. 1983 Nov;128(5):915–919. doi: 10.1164/arrd.1983.128.5.915. [DOI] [PubMed] [Google Scholar]
  4. Capony F., Morisset M., Barrett A. J., Capony J. P., Broquet P., Vignon F., Chambon M., Louisot P., Rochefort H. Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol. 1987 Feb;104(2):253–262. doi: 10.1083/jcb.104.2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chang J. C., Lesser M., Yoo O. H., Orlowski M. Increased cathepsin B-like activity in alveolar macrophages and bronchoalveolar lavage fluid from smokers. Am Rev Respir Dis. 1986 Sep;134(3):538–541. doi: 10.1164/arrd.1986.134.3.538. [DOI] [PubMed] [Google Scholar]
  6. Chapman H. A., Jr, Stone O. L. Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J Clin Invest. 1984 Nov;74(5):1693–1700. doi: 10.1172/JCI111586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Denhardt D. T., Hamilton R. T., Parfett C. L., Edwards D. R., St Pierre R., Waterhouse P., Nilsen-Hamilton M. Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins. Cancer Res. 1986 Sep;46(9):4590–4593. [PubMed] [Google Scholar]
  8. Etherington D. J., Pugh D., Silver I. A. Collagen degradation in an experimental inflammatory lesion: studies on the role of the macrophage. Acta Biol Med Ger. 1981;40(10-11):1625–1636. [PubMed] [Google Scholar]
  9. Gal S., Gottesman M. M. The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity. Biochem Biophys Res Commun. 1986 Aug 29;139(1):156–162. doi: 10.1016/s0006-291x(86)80093-6. [DOI] [PubMed] [Google Scholar]
  10. Gal S., Gottesman M. M. The major excreted protein of transformed fibroblasts is an activable acid-protease. J Biol Chem. 1986 Feb 5;261(4):1760–1765. [PubMed] [Google Scholar]
  11. Gal S., Willingham M. C., Gottesman M. M. Processing and lysosomal localization of a glycoprotein whose secretion is transformation stimulated. J Cell Biol. 1985 Feb;100(2):535–544. doi: 10.1083/jcb.100.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gottesman M. M. Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2767–2771. doi: 10.1073/pnas.75.6.2767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graf M., Leeman U., Ruch F., Sträuli P. The fluorescence and bright field microscopic demonstration of cathepsin B in human fibroblasts. Histochemistry. 1979;64(3):319–322. doi: 10.1007/BF00495033. [DOI] [PubMed] [Google Scholar]
  14. Leary R., Shaw E. Inactivation of cathepsin B1 by diazomethyl ketones. Biochem Biophys Res Commun. 1977 Dec 7;79(3):926–931. doi: 10.1016/0006-291x(77)91199-8. [DOI] [PubMed] [Google Scholar]
  15. Mason R. W., Green G. D., Barrett A. J. Human liver cathepsin L. Biochem J. 1985 Feb 15;226(1):233–241. doi: 10.1042/bj2260233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mason R. W. Species variants of cathepsin L and their immunological identification. Biochem J. 1986 Nov 15;240(1):285–288. doi: 10.1042/bj2400285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mason R. W., Taylor M. A., Etherington D. J. The purification and properties of cathepsin L from rabbit liver. Biochem J. 1984 Jan 1;217(1):209–217. doi: 10.1042/bj2170209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mason R. W., Walker J. E., Northrop F. D. The N-terminal amino acid sequences of the heavy and light chains of human cathepsin L. Relationship to a cDNA clone for a major cysteine proteinase from a mouse macrophage cell line. Biochem J. 1986 Dec 1;240(2):373–377. doi: 10.1042/bj2400373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mort J. S., Recklies A. D. Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J. 1986 Jan 1;233(1):57–63. doi: 10.1042/bj2330057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Parkes C., Kembhavi A. A., Barrett A. J. Calpain inhibition by peptide epoxides. Biochem J. 1985 Sep 1;230(2):509–516. doi: 10.1042/bj2300509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Poole A. R., Mort J. S. Biochemical and immunological studies of lysosomal and related proteinases in health and disease. J Histochem Cytochem. 1981 Mar;29(3A):494–502. doi: 10.1177/29.3.494. [DOI] [PubMed] [Google Scholar]
  22. Portnoy D. A., Erickson A. H., Kochan J., Ravetch J. V., Unkeless J. C. Cloning and characterization of a mouse cysteine proteinase. J Biol Chem. 1986 Nov 5;261(31):14697–14703. [PubMed] [Google Scholar]
  23. Sloane B. F., Honn K. V. Cysteine proteinases and metastasis. Cancer Metastasis Rev. 1984;3(3):249–263. doi: 10.1007/BF00048388. [DOI] [PubMed] [Google Scholar]
  24. WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES